Utama › Atrofi Geografik
Kajian klinikal Atrofi Geografik sedang mengambil peserta di AS
24 kajian untuk Atrofi Geografik sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Dallas, TX8 kajian
- Reno, NV8 kajian
- Austin, TX7 kajian
- Santa Monica, CA7 kajian
- Cleveland, OH6 kajian
- Houston, TX6 kajian
- The Woodlands, TX6 kajian
- Naperville, IL6 kajian
- Baltimore, MD6 kajian
- Spokane, WA5 kajian
- Hagerstown, MD5 kajian
- San Antonio, TX5 kajian
- Washington, DC5 kajian
- St. Louis, MO5 kajian
- Erie, PA5 kajian
- Sacramento, CA5 kajian
- Philadelphia, PA4 kajian
- Fort Worth, TX4 kajian
- Raleigh, NC4 kajian
- Lynchburg, VA4 kajian
- Durham, NC4 kajian
- St. Petersburg, FL4 kajian
- Nashville, TN4 kajian
- Sarasota, FL3 kajian
- Boston, MA3 kajian
- Mountain View, CA3 kajian
- Los Angeles, CA3 kajian
- Pensacola, FL3 kajian
- Salt Lake City, UT3 kajian
- Huntington Beach, CA3 kajian
- Eugene, OR3 kajian
- Cincinnati, OH3 kajian
- Carmel, IN3 kajian
- Concord, CA3 kajian
- Escondido, CA3 kajian
- Syracuse, NY3 kajian
- Phoenix, AZ3 kajian
- Abilene, TX3 kajian
- McAllen, TX3 kajian
- San Francisco, CA3 kajian
Mengikut negeri
- Arizona5 kajian
- California13 kajian
- Colorado4 kajian
- Connecticut4 kajian
- Florida8 kajian
- Georgia4 kajian
- Illinois9 kajian
- Indiana3 kajian
- Maryland7 kajian
- Massachusetts7 kajian
- Michigan5 kajian
- Mississippi3 kajian
- Missouri5 kajian
- Nevada8 kajian
- New Jersey3 kajian
- New York4 kajian
- North Carolina7 kajian
- Ohio7 kajian
- Oregon4 kajian
- Pennsylvania9 kajian
- South Carolina4 kajian
- Tennessee4 kajian
- Texas15 kajian
- Utah4 kajian
- Virginia4 kajian
- Washington6 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Mengambil pesertaFasa 2/3
Umur 60 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06635148Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
Mengambil pesertaFasa 1/2
Umur 55 hingga 95 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT04339764A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
Mengambil pesertaFasa 2
Umur 55 hingga 90 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06557460A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Mengambil pesertaFasa 1/2
Umur 55 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07029945A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Mengambil pesertaFasa 1/2
Umur 60 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07215234A Study in Adults With Geographic Atrophy
Mengambil pesertaFasa 2
Umur 60 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Mengambil pesertaFasa 3
Umur 50 hingga 85 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
Mengambil pesertaFasa 2
Umur 50 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Mengambil pesertaFasa 2
Umur 55 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Mengambil pesertaFasa 1
Umur 50 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT03178149A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Mengambil pesertaKajian pemerhatian
Umur 55 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07144137SGLT2 Inhibitors in Geographic Atrophy
Mengambil pesertaFasa 2
Umur 50 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT07174687Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Mengambil peserta
Umur 60 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06662162A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Mengambil pesertaFasa 2
Umur 55 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06659549Phase 1 Study of C.001 in Retinal Degeneration
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT07594236Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Mengambil pesertaFasa 1
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07230834Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Mengambil pesertaFasa 1/2
Umur 50 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT07160179Stem Cell Ophthalmology Treatment Study II
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT03011541High Resolution Retinal Imaging
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 7 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT01866371Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
Mengambil pesertaKajian pemerhatian
Umur 55 ke atas · Semua jantina · Dikemas kini 29 Apr 2026 · NCT07556406Progression of Early Atrophic Lesions
Mengambil pesertaKajian pemerhatian
Umur 50 ke atas · Semua jantina · Dikemas kini 11 Mac 2026 · NCT05959005A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
Mengambil pesertaFasa 1/2
Umur 50 hingga 85 · Semua jantina · Dikemas kini 23 Jan 2026 · NCT07158775A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Mac 2025 · NCT06805474Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Mengambil peserta
Umur 65 ke atas · Semua jantina · Dikemas kini 3 Dis 2024 · NCT05438732Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.